1. Home
  2. EVG vs EQ Comparison

EVG vs EQ Comparison

Compare EVG & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

EVG

Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

N/A

Current Price

$10.53

Market Cap

142.6M

Sector

Finance

ML Signal

N/A

Logo Equillium Inc.

EQ

Equillium Inc.

N/A

Current Price

$2.40

Market Cap

140.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVG
EQ
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
142.6M
140.1M
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
EVG
EQ
Price
$10.53
$2.40
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
42.2K
412.5K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.40
$0.76
52 Week High
$11.40
$3.54

Technical Indicators

Market Signals
Indicator
EVG
EQ
Relative Strength Index (RSI) 44.71 52.59
Support Level $10.48 $2.36
Resistance Level $10.92 $2.58
Average True Range (ATR) 0.14 0.15
MACD -0.01 0.01
Stochastic Oscillator 28.03 62.46

Price Performance

Historical Comparison
EVG
EQ

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: